Medidata Solutions Company Profile (NASDAQ:MDSO)

About Medidata Solutions (NASDAQ:MDSO)

Medidata Solutions logoMedidata Solutions Inc. (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company's plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments. Study Design Optimization enables customers to gain visibility into the impact of protocol elements on resource and trial endpoints. Grants Manager compares specific industry benchmarks and analytics, using industry's database of negotiated procedure costs, to support appropriate grants to investigator sites and automated negotiations with multiple investigator sites. Payments enables customers to establish a global investigator payment strategy and process to automate payment calculation, distribution and reporting, including tax and currency exchange calculations.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Healthcare Information Services
  • Sub-Industry: Health Care Technology
  • Symbol: NASDAQ:MDSO
  • CUSIP: 58471A10
  • Web:
  • Market Cap: $4.09 billion
  • Outstanding Shares: 56,312,000
Average Prices:
  • 50 Day Moving Avg: $66.71
  • 200 Day Moving Avg: $57.03
  • 52 Week Range: $41.65 - $73.75
  • Trailing P/E Ratio: 123.43
  • Foreward P/E Ratio: 47.21
  • P/E Growth: 2.66
Sales & Book Value:
  • Annual Revenue: $485.96 million
  • Price / Sales: 8.42
  • Book Value: $7.30 per share
  • Price / Book: 9.96
  • EBIDTA: $72.35 million
  • Net Margins: 6.25%
  • Return on Equity: 10.82%
  • Return on Assets: 5.03%
  • Debt-to-Equity Ratio: 0.66%
  • Current Ratio: 3.92%
  • Quick Ratio: 3.80%
  • Average Volume: 456,573 shs.
  • Beta: 1.61
  • Short Ratio: 9.91

Frequently Asked Questions for Medidata Solutions (NASDAQ:MDSO)

What is Medidata Solutions' stock symbol?

Medidata Solutions trades on the NASDAQ under the ticker symbol "MDSO."

How were Medidata Solutions' earnings last quarter?

Medidata Solutions Inc (NASDAQ:MDSO) released its earnings results on Wednesday, April, 26th. The company reported $0.31 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.11 by $0.20. The firm earned $126.80 million during the quarter, compared to the consensus estimate of $125.90 million. Medidata Solutions had a net margin of 6.25% and a return on equity of 10.82%. The company's revenue was up 21.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.25 EPS. View Medidata Solutions' Earnings History.

When will Medidata Solutions make its next earnings announcement?

Medidata Solutions is scheduled to release their next quarterly earnings announcement on Tuesday, July, 18th 2017. View Earnings Estimates for Medidata Solutions.

Where is Medidata Solutions' stock going? Where will Medidata Solutions' stock price be in 2017?

9 equities research analysts have issued twelve-month price targets for Medidata Solutions' stock. Their forecasts range from $46.00 to $75.00. On average, they expect Medidata Solutions' stock price to reach $66.75 in the next year. View Analyst Ratings for Medidata Solutions.

What are analysts saying about Medidata Solutions stock?

Here are some recent quotes from research analysts about Medidata Solutions stock:

  • 1. According to Zacks Investment Research, "Medidata Solutions is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers' clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer), investigator benchmarking and budgeting (Medidata Grants Manager), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave). Medidata's diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes some top global pharmaceutical companies. " (5/17/2017)
  • 2. Jefferies Group LLC analysts commented, "Based on several triangulations, FY17 revenue guidance appears to mark a very accurate target at the midpoint (not too high or low). The 18.7% midpoint growth would need to further accelerate to 22% in '18-'20 to achieve management's $1B goal by '20. Beating the '16 sales performance seems like a tall order. MDSO now trades at 5.6x '17 revenue compared to 4.4x for SaaS peers with similar growth." (2/10/2017)

Are investors shorting Medidata Solutions?

Medidata Solutions saw a increase in short interest during the month of April. As of April 28th, there was short interest totalling 4,571,669 shares, an increase of 0.0% from the April 13th total of 4,569,602 shares. Based on an average daily volume of 555,520 shares, the short-interest ratio is presently 8.2 days.

Who are some of Medidata Solutions' key competitors?

Who are Medidata Solutions' key executives?

Medidata Solutions' management team includes the folowing people:

  • Tarek A. Sherif, Chairman of the Board, Chief Executive Officer
  • Glen M. de Vries, President, Director
  • Rouven Bergmann, Chief Financial Officer
  • Michael L. Capone, Chief Operating Officer
  • Michael I. Otner, Executive Vice President, General Counsel, Corporate Secretary
  • Michael Christopher Pray, Executive Vice President, General Manager - Global Sales
  • Mary Weger, Executive Vice President—Human Resources
  • Carlos Dominguez, Independent Director
  • Neil M. Kurtz M.D., Independent Director
  • George W. McCulloch, Independent Director

Who owns Medidata Solutions stock?

Medidata Solutions' stock is owned by many different of retail and institutional investors. Top institutional investors include Brown Capital Management LLC (10.56%), FMR LLC (10.06%), Vanguard Group Inc. (8.69%), Champlain Investment Partners LLC (2.95%), State Street Corp (2.54%) and Global Thematic Partners LLC (1.56%). Company insiders that own Medidata Solutions stock include Eileen Schloss, Lee Shapiro, Michael I Otner, Michael L Capone, Neil M Kurtz, Robert Taylor, Steven Isaac Hirschfeld, Tarek Sherif and Vries Glen Michael De. View Institutional Ownership Trends for Medidata Solutions.

Who sold Medidata Solutions stock? Who is selling Medidata Solutions stock?

Medidata Solutions' stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Credit Suisse AG, Metropolitan Life Insurance Co. NY, Ranger Investment Management L.P., American Century Companies Inc., Century Capital Management LLC, Janus Capital Management LLC and AXA. Company insiders that have sold Medidata Solutions stock in the last year include Eileen Schloss, Michael I Otner, Michael L Capone, Robert Taylor, Steven Isaac Hirschfeld, Tarek Sherif and Vries Glen Michael De. View Insider Buying and Selling for Medidata Solutions.

Who bought Medidata Solutions stock? Who is buying Medidata Solutions stock?

Medidata Solutions' stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Teachers Advisors LLC, Vanguard Group Inc., Global Thematic Partners LLC, State Street Corp, Henderson Group PLC, Nationwide Fund Advisors and Champlain Investment Partners LLC. View Insider Buying and Selling for Medidata Solutions.

How do I buy Medidata Solutions stock?

Shares of Medidata Solutions can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Medidata Solutions' stock price today?

One share of Medidata Solutions stock can currently be purchased for approximately $72.70.

MarketBeat Community Rating for Medidata Solutions (NASDAQ MDSO)
Community Ranking:  3.3 out of 5 (  )
Outperform Votes:  273 (Vote Outperform)
Underperform Votes:  135 (Vote Underperform)
Total Votes:  408
MarketBeat's community ratings are surveys of what our community members think about Medidata Solutions and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Medidata Solutions (NASDAQ:MDSO) (?)
Ratings Breakdown: 2 Hold Ratings, 7 Buy Ratings
Consensus Rating:Buy (Score: 2.78)
Consensus Price Target: $66.75 (8.18% downside)

Analysts' Ratings History for Medidata Solutions (NASDAQ:MDSO)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/11/2017KeyCorpBoost Price TargetOverweight$71.00 -> $74.00LowView Rating Details
5/1/2017Jefferies Group LLCUpgradeUnderperform -> Hold$47.00 -> $46.00MediumView Rating Details
4/28/2017Morgan StanleyBoost Price TargetOverweight$63.00 -> $74.00LowView Rating Details
4/27/2017Needham & Company LLCBoost Price TargetBuy -> Buy$65.00 -> $75.00HighView Rating Details
4/11/2017Piper Jaffray CompaniesBoost Price TargetOverweight$60.00 -> $72.00LowView Rating Details
2/10/2017SunTrust Banks, Inc.UpgradeNeutral -> Buy$60.00 -> $70.00N/AView Rating Details
12/4/2016Pacific CrestSet Price TargetBuy$65.00N/AView Rating Details
9/13/2016Deutsche Bank AGBoost Price TargetBuy$56.00 -> $58.00N/AView Rating Details
7/21/2016Wells Fargo & CoDowngradeOutperform -> Market PerformN/AView Rating Details
4/25/2016Leerink SwannReiterated RatingMarket PerformN/AView Rating Details
4/22/2016Citigroup IncBoost Price TargetBuy$40.00 -> $55.00N/AView Rating Details
4/22/2016Topeka Capital MarketsReiterated RatingBuy$44.00 -> $51.00N/AView Rating Details
10/28/2015Stifel NicolausLower Price TargetBuy$65.00 -> $60.00N/AView Rating Details
(Data available from 5/29/2015 forward)


Earnings History for Medidata Solutions (NASDAQ:MDSO)
Earnings by Quarter for Medidata Solutions (NASDAQ:MDSO)
Earnings History by Quarter for Medidata Solutions (NASDAQ:MDSO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/26/2017Q1 2017$0.11$0.31$125.90 million$126.80 millionViewN/AView Earnings Details
2/9/2017Q416$0.26$0.33$124.15 million$124.50 millionViewListenView Earnings Details
10/25/2016Q316$0.26$0.28$118.96 million$120.10 millionViewListenView Earnings Details
7/20/2016Q216$0.23$0.24$112.39 million$114.60 millionViewListenView Earnings Details
4/21/2016Q116$0.18$0.25$103.22 million$104.20 millionViewListenView Earnings Details
2/10/2016Q415$0.24$0.27$105.09 million$98.90 millionViewListenView Earnings Details
10/27/2015Q315$0.24$0.12$103.49 million$103.10 millionViewListenView Earnings Details
7/21/2015Q215$0.20$0.22$97.27 million$98.10 millionViewListenView Earnings Details
4/23/2015Q115$0.02$0.17$91.05 million$92.40 millionViewListenView Earnings Details
2/5/2015Q414$0.10$0.15$91.12 million$89.20 millionViewListenView Earnings Details
10/28/2014Q314$0.22$0.20$87.72 million$86.00 millionViewN/AView Earnings Details
7/29/2014Q214$0.07$0.04$81.90 million$83.20 millionViewListenView Earnings Details
4/22/2014Q114$0.16$0.11$79.50 million$76.60 millionViewListenView Earnings Details
2/6/2014Q413$0.17$0.23$73.97 million$74.60 millionViewListenView Earnings Details
10/24/2013Q313$0.33$0.40$70.74 million$70.90 millionViewN/AView Earnings Details
7/25/2013Q2 2013$0.12$0.20$66.71 million$68.07 millionViewN/AView Earnings Details
4/29/2013Q1 2013$0.23$0.35$61.32 million$63.30 millionViewN/AView Earnings Details
2/21/2013Q4 2012$0.28$0.35$59.12 million$58.60 millionViewN/AView Earnings Details
10/31/2012$0.31$0.29ViewN/AView Earnings Details
7/31/2012$0.23$0.23ViewN/AView Earnings Details
5/1/2012$0.22$0.26ViewN/AView Earnings Details
3/6/2012$0.37$0.37ViewN/AView Earnings Details
11/8/2011$0.34$0.42ViewN/AView Earnings Details
8/9/2011$0.33$0.40ViewN/AView Earnings Details
5/10/2011$0.23$0.21ViewN/AView Earnings Details
3/15/2011$0.26$0.29ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Medidata Solutions (NASDAQ:MDSO)
2017 EPS Consensus Estimate: $0.69
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.11$0.11$0.11
Q2 20171$0.16$0.16$0.16
Q3 20171$0.20$0.20$0.20
Q4 20171$0.22$0.22$0.22
(Data provided by Zacks Investment Research)


Dividend History for Medidata Solutions (NASDAQ:MDSO)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Medidata Solutions (NASDAQ:MDSO)
Insider Ownership Percentage: 6.70%
Institutional Ownership Percentage: 99.63%
Insider Trades by Quarter for Medidata Solutions (NASDAQ:MDSO)
Institutional Ownership by Quarter for Medidata Solutions (NASDAQ:MDSO)
Insider Trades by Quarter for Medidata Solutions (NASDAQ:MDSO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/15/2017Michael L CaponeCOOSell5,000$69.46$347,300.00View SEC Filing  
5/1/2017Michael I OtnerEVPSell7,500$66.39$497,925.00View SEC Filing  
4/4/2017Tarek SherifCEOSell2,964$57.08$169,185.12View SEC Filing  
3/9/2017Vries Glen Michael DePresidentSell7,500$56.05$420,375.00View SEC Filing  
3/2/2017Tarek SherifCEOSell7,500$57.06$427,950.00View SEC Filing  
2/14/2017Michael L. CaponeCOOSell5,000$56.14$280,700.00View SEC Filing  
1/25/2017Steven Isaac HirschfeldVice ChairmanSell10,000$50.83$508,300.00View SEC Filing  
1/11/2017Vries Glen Michael DePresidentSell7,500$52.44$393,300.00View SEC Filing  
1/4/2017Tarek SherifCEOSell7,500$51.56$386,700.00View SEC Filing  
12/21/2016Steven Isaac HirschfeldVice ChairmanSell10,000$51.02$510,200.00View SEC Filing  
12/2/2016Tarek SherifCEOSell7,500$52.68$395,100.00View SEC Filing  
11/30/2016Steven Isaac HirschfeldVice ChairmanSell10,000$54.87$548,700.00View SEC Filing  
11/16/2016Eileen SchlossEVPSell3,831$56.60$216,834.60View SEC Filing  
11/16/2016Steven Isaac HirschfeldVice ChairmanSell156$57.85$9,024.60View SEC Filing  
11/9/2016Vries Glen Michael DePresidentSell7,500$50.85$381,375.00View SEC Filing  
11/2/2016Tarek SherifCEOSell7,500$46.70$350,250.00View SEC Filing  
10/26/2016Steven Isaac HirschfeldVice ChairmanSell10,000$48.50$485,000.00View SEC Filing  
10/25/2016Michael I OtnerEVPSell7,331$53.87$394,920.97View SEC Filing  
10/11/2016Vries Glen Michael DePresidentSell7,500$54.72$410,400.00View SEC Filing  
10/4/2016Tarek SherifCEOSell7,500$54.86$411,450.00View SEC Filing  
9/28/2016Steven Isaac HirschfeldVice ChairmanSell10,000$56.17$561,700.00View SEC Filing  
9/12/2016Vries Glen Michael DePresidentSell7,500$53.70$402,750.00View SEC Filing  
9/7/2016Steven Isaac HirschfeldVice ChairmanSell10,000$55.85$558,500.00View SEC Filing  
9/2/2016Tarek SherifCEOSell7,500$54.33$407,475.00View SEC Filing  
8/31/2016Steven Isaac HirschfeldVice ChairmanSell10,000$54.11$541,100.00View SEC Filing  
8/29/2016Michael I OtnerEVPSell6,006$53.92$323,843.52View SEC Filing  
8/9/2016Vries Glen Michael DePresidentSell7,500$54.39$407,925.00View SEC Filing  
8/2/2016Tarek SherifCEOSell7,500$52.97$397,275.00View SEC Filing  
7/29/2016Eileen SchlossEVPSell2,083$53.04$110,482.32View SEC Filing  
7/27/2016Steven Isaac HirschfeldVice ChairmanSell10,000$52.77$527,700.00View SEC Filing  
7/26/2016Eileen SchlossEVPSell10,644$52.82$562,216.08View SEC Filing  
7/22/2016Michael I. OtnerEVPSell7,500$51.27$384,525.00View SEC Filing  
7/20/2016Steven Isaac HirschfeldVice ChairmanSell20,825$52.89$1,101,434.25View SEC Filing  
7/12/2016Steven Isaac HirschfeldVice ChairmanSell10,000$49.85$498,500.00View SEC Filing  
7/12/2016Tarek SherifCEOSell22,036$49.24$1,085,052.64View SEC Filing  
7/12/2016Vries Glen Michael DePresidentSell32,500$49.25$1,600,625.00View SEC Filing  
7/5/2016Tarek SherifCEOSell7,500$46.35$347,625.00View SEC Filing  
6/29/2016Steven Isaac HirschfeldVice ChairmanSell10,000$45.66$456,600.00View SEC Filing  
6/9/2016Vries Glen Michael DePresidentSell7,500$47.66$357,450.00View SEC Filing  
6/2/2016Tarek SherifCEOSell7,500$45.90$344,250.00View SEC Filing  
5/31/2016Robert TaylorDirectorSell3,752$45.03$168,952.56View SEC Filing  
5/25/2016Neil M KurtzDirectorSell5,937$44.95$266,868.15View SEC Filing  
5/25/2016Steven Isaac HirschfeldVice ChairmanSell10,000$44.94$449,400.00View SEC Filing  
5/25/2016Tarek SherifCEOSell7,500$45.00$337,500.00View SEC Filing  
4/27/2016Steven Isaac HirschfeldVice ChairmanSell10,000$45.09$450,900.00View SEC Filing  
4/25/2016Eileen SchlossEVPSell68,717$46.53$3,197,402.01View SEC Filing  
4/25/2016Vries Glen Michael DePresidentSell7,500$46.36$347,700.00View SEC Filing  
2/16/2016Lee ShapiroDirectorBuy1,500$33.45$50,175.00View SEC Filing  
7/21/2015Steven Isaac HirschfeldInsiderSell5,293$61.00$322,873.00View SEC Filing  
7/20/2015Steven Isaac HirschfeldInsiderSell4,908$59.00$289,572.00View SEC Filing  
5/29/2015Eileen SchlossEVPSell2,084$57.10$118,996.40View SEC Filing  
5/29/2015Robert TaylorDirectorSell5,048$56.81$286,776.88View SEC Filing  
5/14/2015Steven Isaac HirschfeldInsiderSell22,153$53.36$1,182,084.08View SEC Filing  
4/29/2015Eileen SchlossEVPSell4,166$55.20$229,963.20View SEC Filing  
4/28/2015Cory DouglasCFOSell12,333$55.29$681,891.57View SEC Filing  
3/23/2015Vries Glen Michael DePresidentSell20,000$49.89$997,800.00View SEC Filing  
2/18/2015Eileen SchlossEVPSell12,065$46.98$566,813.70View SEC Filing  
2/17/2015Michael I OtnerEVPSell11,010$46.75$514,717.50View SEC Filing  
2/10/2015Bryan Charles SpielmanEVPSell5,851$45.00$263,295.00View SEC Filing  
2/10/2015Robert TaylorDirectorSell28,672$44.07$1,263,575.04View SEC Filing  
2/9/2015Cory DouglasCFOSell38,000$44.24$1,681,120.00View SEC Filing  
2/9/2015Eileen SchlossEVPSell12,499$44.43$555,330.57View SEC Filing  
12/4/2014Steven Isaac HirschfeldInsiderSell22,075$42.53$938,849.75View SEC Filing  
11/19/2014Michael L CaponeCOOBuy2,400$40.01$96,024.00View SEC Filing  
10/3/2014Tarek SherifCEOSell20,000$45.30$906,000.00View SEC Filing  
9/9/2014Vries Glen Michael DePresidentSell20,000$48.51$970,200.00View SEC Filing  
8/26/2014Bryan Charles SpielmanEVPSell20,000$47.73$954,600.00View SEC Filing  
8/22/2014Steven Isaac HirschfeldEVPSell23,801$44.00$1,047,244.00View SEC Filing  
8/7/2014Michael I OtnerEVPSell10,000$44.84$448,400.00View SEC Filing  
8/5/2014Tarek SherifCEOSell20,000$44.81$896,200.00View SEC Filing  
8/4/2014Bryan Charles SpielmanEVPSell2,261$45.00$101,745.00View SEC Filing  
7/8/2014Vries Glen Michael DePresidentSell20,000$40.13$802,600.00View SEC Filing  
7/7/2014Tarek SherifCEOSell20,000$43.20$864,000.00View SEC Filing  
6/17/2014Tarek SherifCEOSell19,818$40.27$798,070.86View SEC Filing  
6/17/2014Vries Glen Michael DePresidentSell20,000$40.26$805,200.00View SEC Filing  
4/8/2014Vries Glen Michael DePresidentSell20,000$47.71$954,200.00View SEC Filing  
4/3/2014Tarek SherifCEOSell20,000$55.05$1,101,000.00View SEC Filing  
2/19/2014Eileen SchlossEVPSell16,847$60.76$1,023,623.72View SEC Filing  
2/18/2014Steven Isaac HirschfeldEVPSell17,000$60.03$1,020,510.00View SEC Filing  
2/11/2014Vries Glen Michael DePresidentSell20,000$54.40$1,088,000.00View SEC Filing  
1/14/2014Vries Glen Michael DePresidentSell20,000$59.35$1,187,000.00View SEC Filing  
1/6/2014Tarek SherifCEOSell20,000$59.44$1,188,800.00View SEC Filing  
12/13/2013Steven Isaac HirschfeldEVPSell10,000$113.01$1,130,100.00View SEC Filing  
12/11/2013Steven Isaac HirschfeldEVPSell10,000$116.59$1,165,900.00View SEC Filing  
12/10/2013Vries Glen Michael DePresidentSell10,000$116.39$1,163,900.00View SEC Filing  
12/6/2013Tarek SherifCEOSell53,290$118.08$6,292,483.20View SEC Filing  
12/6/2013Vries Glen Michael DePresidentSell43,289$118.11$5,112,863.79View SEC Filing  
11/12/2013Cory DouglasCFOSell10,000$108.08$1,080,800.00View SEC Filing  
11/1/2013Cory DouglasCFOSell30,000$109.59$3,287,700.00View SEC Filing  
10/29/2013Eileen SchlossEVPSell12,500$116.08$1,451,000.00View SEC Filing  
10/28/2013Lee ShapiroDirectorSell3,800$117.48$446,424.00View SEC Filing  
10/28/2013Michael I OtnerEVPSell5,071$117.45$595,588.95View SEC Filing  
9/16/2013Bryan Charles SpielmanEVPSell3,905$99.47$388,430.35View SEC Filing  
8/1/2013Michael I OtnerEVPSell2,500$92.16$230,400.00View SEC Filing  
7/26/2013Vries Glen Michael DePresidentSell56,547$90.08$5,093,753.76View SEC Filing  
7/25/2013Bryan Charles SpielmanEVPSell4,145$86.66$359,205.70View SEC Filing  
7/1/2013Bryan Charles SpielmanEVPSell3,950$78.78$311,181.00View SEC Filing  
6/28/2013Steven Isaac HirschfeldEVPSell5,486$76.84$421,544.24View SEC Filing  
6/5/2013Steven Isaac HirschfeldEVPSell5,189$68.84$357,210.76View SEC Filing  
5/22/2013Steven Isaac HirschfeldEVPSell10,711$67.60$724,063.60View SEC Filing  
5/10/2013Robert TaylorDirectorSell4,533$70.31$318,715.23View SEC Filing  
5/1/2013Neil M KurtzDirectorSell5,910$66.02$390,178.20View SEC Filing  
2/25/2013Lineene Norris KrasnowEVPSell18,690$50.39$941,789.10View SEC Filing  
2/22/2013Vries Glen Michael DePresidentSell56,547$50.20$2,838,659.40View SEC Filing  
10/4/2012Tarek SherifCEOSell40,000$39.47$1,578,800.00View SEC Filing  
10/3/2012Vries Glen Michael DePresidentSell27,604$39.77$1,097,811.08View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Medidata Solutions (NASDAQ:MDSO)
Latest Headlines for Medidata Solutions (NASDAQ:MDSO)
DateHeadline logoMedidata to Present at Bank of America Merrill Lynch 2017 Global Technology Conference - May 26 at 3:55 AM logoMedidata Solutions Inc (MDSO) Cut to "Hold" at Zacks Investment Research - May 19 at 12:08 AM logoMedidata to Present First-of-its-kind Scientific Innovation at 2017 ASCO Annual Meeting - May 17 at 6:26 PM logoMedidata Solutions Inc (MDSO) COO Michael L. Capone Sells 5,000 Shares - May 16 at 7:33 PM logoUPDATED PRESENTATION TIME FOR MAY 22: Medidata to Present at Upcoming Investor Conference - May 15 at 5:53 PM logoMedytox to Further Expand Global Presence by Increasing Its Adoption of the Medidata Clinical Cloud® - May 15 at 5:53 PM logoMedidata Solutions Inc (MDSO) Short Interest Up 0.0% in April - May 13 at 7:34 AM logoMedidata’s Julie Iskow Named a “Luminary” by the Healthcare Businesswomen’s Association - May 11 at 7:00 PM logoMedidata Solutions Inc (MDSO) Rating Reiterated by KeyCorp - May 11 at 5:24 PM logoMedidata Solutions Inc (MDSO) Expected to Announce Quarterly Sales of $134.42 Million - May 7 at 9:40 AM logoMedidata Solutions Inc (MDSO) Expected to Post Earnings of $0.17 Per Share - May 5 at 10:40 AM logoMedidata Solutions Inc (MDSO) Given Average Rating of "Buy" by Brokerages - May 5 at 9:50 AM logoQ3 2017 Earnings Forecast for Medidata Solutions Inc Issued By Jefferies Group (MDSO) - May 4 at 1:38 PM logoMedidata Solutions Inc (MDSO) Upgraded by Zacks Investment Research to "Buy" - May 4 at 1:17 AM logoMedidata Solutions Inc (MDSO) Upgraded to "Buy" at Zacks Investment Research - May 4 at 1:16 AM logoMichael I. Otner Sells 7,500 Shares of Medidata Solutions Inc (MDSO) Stock - May 3 at 10:40 PM logoPositive Press Coverage Likely to Impact Medidata Solutions (MDSO) Share Price - May 3 at 4:22 PM logoFY2017 EPS Estimates for Medidata Solutions Inc Lifted by Analyst (MDSO) - May 3 at 1:11 PM logoMedidata Solutions Inc (MDSO) Upgraded by Jefferies Group LLC to "Hold" - May 1 at 11:48 AM logoSomewhat Positive News Coverage Very Likely to Affect Medidata Solutions (MDSO) Share Price - April 30 at 2:41 PM logoMedidata Solutions Inc (MDSO) Given "Sell" Rating at Jefferies Group LLC - April 29 at 4:26 PM logoMedidata Solutions Inc (MDSO) Earns Overweight Rating from Morgan Stanley - April 28 at 4:20 PM logoMedidata Solutions (MDSO) Getting Somewhat Favorable Media Coverage, Study Finds - April 27 at 11:52 PM logoMedidata Solutions Inc (MDSO) Given New $75.00 Price Target at Needham & Company LLC - April 27 at 11:38 PM logoEdited Transcript of MDSO earnings conference call or presentation 26-Apr-17 12:00pm GMT - April 27 at 7:01 PM logoForm 8-K Medidata Solutions, Inc. For: Apr 26 - April 26 at 11:50 PM logoMedidata Solutions Backs 2017 Outlook - April 26 at 11:50 PM logoUCB Selects Medidata Clinical Cloud® to Support Patient-Centric Drug Development - April 26 at 6:48 PM logoMedidata Reports Record First Quarter 2017 Results - April 26 at 6:48 PM logoMedidata Solutions Inc (MDSO) Posts Quarterly Earnings Results, Beats Estimates By $0.07 EPS - April 26 at 6:30 PM logoMedidata beats Street 1Q forecasts - April 26 at 7:23 AM logoWuXi Clinical Development Services Expands Use of Medidata’s Cloud Technology Platform - April 24 at 7:18 PM logoSomewhat Positive Media Coverage Extremely Likely to Impact Medidata Solutions (MDSO) Share Price - April 24 at 7:04 PM logoNeedham & Company LLC Reiterates "Buy" Rating for Medidata Solutions Inc (MDSO) - April 19 at 4:22 PM logoDavis medical data firm acquired by big, publicly traded company - April 18 at 10:28 AM logoMedidata Solutions Inc (MDSO) Price Target Increased to $72.00 by Analysts at Piper Jaffray Companies - April 17 at 11:10 AM logoMedidata to Acquire Mytrus to Take Next Step in Transforming the Clinical Trial Patient Experience - April 17 at 10:18 AM logoSomewhat Positive News Coverage Somewhat Likely to Effect Medidata Solutions (MDSO) Share Price - April 16 at 1:50 PM logoMedidata Solutions Inc (MDSO) Expected to Post Quarterly Sales of $125.75 Million - April 16 at 9:48 AM logoMedidata Solutions Inc (MDSO) Price Target Raised to $72.00 - April 14 at 6:04 PM logo Brokerages Expect Medidata Solutions Inc (MDSO) to Announce $0.11 Earnings Per Share - April 14 at 11:02 AM logoMedidata Solutions Inc (MDSO) Downgraded to Hold at Zacks Investment Research - April 13 at 9:58 PM logoMedidata Solutions (MDSO) Given News Sentiment Score of 0.21 - April 13 at 8:15 PM logoMedidata Schedules First Quarter Earnings Conference Call for April 26, 2017 - April 12 at 7:24 PM logoMedidata Solutions Inc. (MDSO) Broke Out To A New High For The Year - April 10 at 10:33 AM logoMedidata Solutions Inc (MDSO) Receives Average Rating of "Buy" from Brokerages - April 10 at 9:50 AM logoMedidata Wins Informa CARE Award for “Clinical Trial Partnership of the Year” - April 7 at 11:08 AM logoTarek Sherif Sells 2,964 Shares of Medidata Solutions Inc (MDSO) Stock - April 6 at 7:57 PM logoMedidata’s Clinical Technology Platform Selected for Groundbreaking “Beat AML Master Trial” - March 23 at 7:02 PM logoMEDIDATA SOLUTIONS, INC. Financials - March 4 at 6:36 PM



Medidata Solutions (MDSO) Chart for Monday, May, 29, 2017

This page was last updated on 5/29/2017 by Staff